Prof. Saritha S
Pathology
July 2024
It is imperative for healthcare systems globally to guarantee a dependable and secure blood product supply. This research investigates how the supply chain for blood products is affected by the adoption of strict quality control measures. Blood components such as Red Cell Concentrate (RCC), Fresh Frozen Plasma (FFP), Platelet Concentrate (PC), Cryoprecipitate (CP), and Platelet Apheresis were analyzed in a study carried out at A.D. Gorwala Blood Bank between April 2021 and March 2023. A minimum of four bags or 1% of each component were randomly selected each month for quality control assessment using information from the blood banks online programmed. The sample selection process included all blood bags excluding those collected through therapeutic phlebotomy. Factor VIII activity, sterility, platelet count, pH, fibrinogen levels, hemoglobin content, hematocrit, leukocyte count, volume, and quality control criteria in line with National Accreditation Board for Hospitals and Healthcare Providers (NABH) standards were used. When analyzing the data, descriptive statistics were utilized to guarantee that strict quality requirements were followed and to emphasize the effectiveness and safety of blood components for transfusion and medicinal purposes. Improved transfusion methods and patient outcomes are made possible by this thorough evaluation. In order to ensure a stable and effective supply of blood products, which ultimately improves patient safety and healthcare delivery, the results highlight the significance of strict quality control.
90- 102
© Airo Journals 2021
